0000912061-19-000065.txt : 20190813 0000912061-19-000065.hdr.sgml : 20190813 20190813120949 ACCESSION NUMBER: 0000912061-19-000065 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20190809 ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190813 DATE AS OF CHANGE: 20190813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL HEALTH TRENDS CORP CENTRAL INDEX KEY: 0000912061 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MISCELLANEOUS NONDURABLE GOODS [5190] IRS NUMBER: 592705336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36849 FILM NUMBER: 191019206 BUSINESS ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 BUSINESS PHONE: 852-3107-0800 MAIL ADDRESS: STREET 1: UNITS 1205-07, 12F, MIRA PLACE TOWER A STREET 2: 132 NATHAN ROAD, TSIMSHATSUI, KOWLOON CITY: HONG KONG STATE: K3 ZIP: 00000 8-K 1 nhtc20190813_8k.htm 8-K Document
false0000912061 0000912061 2019-08-09 2019-08-09


UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
 
August 9, 2019
 
Date of Report (Date of earliest event reported)
 
 NATURAL HEALTH TRENDS CORP.
(Exact name of registrant as specified in its charter)
Delaware
001-36849
59-2705336
(State or other jurisdiction of incorporation)        
(Commission File Number)  
(IRS Employer Identification No.)
 
 
 

 Units 1205-07, 12F, Mira Place Tower A, 132 Nathan Road, Tsimshatsui, Kowloon, Hong Kong
(Address of principal executive offices, including zip code)

+852-3107-0800
(Registrant’s telephone number, including area code)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
NHTC
The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

   Emerging growth company

o   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.







Item 3.02
Unregistered Sales of Equity Securities.

Reference is made to the disclosure set forth in Item 5.02 below (including the use of various defined terms). Pursuant to the terms of the Amendment, on August 9, 2019, the Company awarded 1,117,485 shares of restricted common stock under the Equity Plan, subject to quarterly vesting for the three-year period following the date of award. The shares of restricted stock were awarded in lieu of aggregate unpaid cash benefits of $7.9 million earned under the Plan for performance periods ending on or prior to December 31, 2018. The shares of restricted stock awarded to United States participants were exempt from registration as a limited offering pursuant to Rule 506 of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”), and the shares of restricted stock awarded to non-United States participants were exempt from registration as they were made outside the United States pursuant to Regulation S promulgated under the Securities Act.

Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The Compensation Committee of Natural Health Trends Corp. (the “Company”) adopted the Second Amendment to the Natural Health Trends Corp. 2014 Long-Term Incentive Plan (Restated as of January 1, 2016) (the “Plan”) on August 9, 2019 (the “Amendment’). Pursuant to the terms of the Amendment, all unpaid cash benefits earned by currently employed participants under the Plan with respect to performance periods that concluded on prior to December 31, 2018 were paid in the form of the award of shares of restricted stock. The restricted stock awards were issued under the Natural Health Trends Corp. 2016 Equity Incentive Plan (the “Equity Plan”) pursuant to the authorized form of restricted stock award agreement, which provides for vesting in quarterly increments over three years following the date of grant, subject to the participant’s continued employment with the Company. Pursuant to the terms of the Amendment, Chris T. Sharng received 408,071 shares of restricted stock for unpaid cash benefits under the Plan of $2.9 million, and Timothy S. Davidson received 156,583 shares of restrictive stock for unpaid cash benefits under the Plan of $1.1 million. In addition, each participant that received shares of restricted stock is also entitled to receive certain gross-up payments for income taxes payable in connection with the awarded shares.

Item 9.01     Financial Statements and Exhibits.

(d) Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 13, 2019

 
NATURAL HEALTH TRENDS CORP.
 
 
 
 
 
 
 
 
 
By:
/s/ Timothy S. Davidson
 
 
 
Timothy S. Davidson
 
 
 
Senior Vice President and Chief Financial Officer
 





EXHIBIT INDEX




EX-10.1 2 secondamendlti.htm EXHIBIT 10.1 Exhibit



SECOND AMENDMENT TO THE
NATURAL HEALTH TRENDS CORP. 2014 LONG-TERM INCENTIVE PLAN
(RESTATED AS OF JANUARY 1, 2016)

THIS AMENDMENT to the Natural Health Trends Corp. 2014 Long-Term Incentive Plan, Restated as of January 1, 2016 (the “Plan”), is hereby adopted by Natural Health Trends Corp., a Delaware corporation (the “Company”), to be effective as of August 9, 2019 (the “Effective Date”).

WITNESSETH

WHEREAS, the Company sponsors the Plan for the benefit of eligible employees of the Company;

WHEREAS, the Plan provides that amounts payable to participants will be paid in a combination of cash and common stock of the Company, provided the recipient remains continuously employed by the Company as of the date on which a distribution is made;

WHEREAS, the Company currently distributes all common stock payable under the Plan in the form of awards from the Natural Health Trends Corp. 2016 Equity Incentive Plan (the “Equity Plan”); and

WHEREAS, the Company desires to amend the Plan to provide that, to the extent all or a portion of the cash benefits ‎earned by participants that are currently employed by the Company with respect to Performance Periods that concluded on or prior to December 31, 2018 remain unpaid, such unpaid benefits ‎shall be paid in the form of an award of the Company’s common stock under the Equity Plan (based upon the closing price of the Company’s ‎common stock as of the Effective Date), subject to all the terms of the Equity Plan and ‎applicable award agreement, including but not limited to a three-year quarterly vesting schedule‎;

NOW, THEREFORE, Section 5.2 of the Plan is amended by adding a new subsection (e) to provide as follows, effective as of the Effective Date:

(e)
Special Rule Affecting Certain 2019 Distributions. Notwithstanding any provision of this Section to the contrary,‎ the portion of an Individual Award Opportunity for a Performance Period that concluded on or before December 31, 2018 and that remains undistributed under Section 5.2(b) as of August 9, 2019 (the “Conversion Date”) shall be distributed in the form of an award of a number of whole ‎shares of Common Stock having an ‎equivalent cash value to the undistributed benefit under Section 5.2(b) based upon the closing price of the Common Stock as of the Conversion Date.‎ To be eligible to receive a distribution under this Section 5.2(e), a Participant must have ‎remained in a continuous employment or other service provider relationship ‎with the Company, Parent, or a Subsidiary through the Conversion Date. This distribution will take the form of an award under the Natural ‎Health Trends Corp. 2016 Equity Incentive Plan, subject to the terms, including ‎vesting, of the





applicable plan and award agreement under which ‎such award is made. ‎ In no event will any distribution under this Section 5.2(e) be delayed ‎to such an extent that the amount would be treated as non-‎qualified deferred compensation under Section 409A of the Code.‎ Distribution under this Section 5.2(e) will fully satisfy the Company’s payment obligations under Section 5.2(b) with respect to any Performance Period that concluded on or before December 31, 2018.

IN WITNESS WHEREOF, the undersigned has executed this Amendment this 9th day of August, 2019.

NATURAL HEALTH TRENDS CORP.

By:    /s/ Timothy S. Davidson            
Timothy S. Davidson

Title:    Chief Financial Officer


EX-101.SCH 3 nhtc-20190809.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Cover page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 nhtc-20190809_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 nhtc-20190809_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 nhtc-20190809_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover page. Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, Address Line Three Entity Address, City or Town Entity Address, City or Town Entity Address, Country Entity Address, Country City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag EX-101.PRE 7 nhtc-20190809_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 nhtc20190813_8k_htm.xml IDEA: XBRL DOCUMENT 0000912061 2019-08-09 2019-08-09 false 0000912061 8-K 2019-08-09 NATURAL HEALTH TRENDS CORP. DE 001-36849 59-2705336 Units 1205-07, 12F Mira Place Tower A 132 Nathan Road Tsimshatsui HK 852 3107-0800 false false false false Common Stock, par value $0.001 per share NHTC NASDAQ false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.19.2
Cover page
Aug. 09, 2019
Cover page.  
Document Type 8-K
Document Period End Date Aug. 09, 2019
Entity Registrant Name NATURAL HEALTH TRENDS CORP.
Entity Incorporation, State or Country Code DE
Entity File Number 001-36849
Entity Tax Identification Number 59-2705336
Entity Address, Address Line One Units 1205-07, 12F
Entity Address, Address Line Two Mira Place Tower A
Entity Address, Address Line Three 132 Nathan Road
Entity Address, City or Town Tsimshatsui
Entity Address, Country HK
City Area Code 852
Local Phone Number 3107-0800
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol NHTC
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000912061
Amendment Flag false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.2 html 1 97 1 false 0 0 false 0 false false R1.htm 0001000 - Document - Cover page Sheet http://www.naturalhealthtrendscorp.com/role/CoverPage Cover page Cover 1 false false All Reports Book All Reports nhtc20190813_8k.htm nhtc-20190809.xsd nhtc-20190809_cal.xml nhtc-20190809_def.xml nhtc-20190809_lab.xml nhtc-20190809_pre.xml secondamendlti.htm http://xbrl.sec.gov/dei/2019-01-31 true true JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nhtc20190813_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "nhtc-20190809_cal.xml" ] }, "definitionLink": { "local": [ "nhtc-20190809_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "nhtc20190813_8k.htm" ] }, "labelLink": { "local": [ "nhtc-20190809_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "nhtc-20190809_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "nhtc-20190809.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nhtc", "nsuri": "http://www.naturalhealthtrendscorp.com/20190809", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nhtc20190813_8k.htm", "contextRef": "D2019Q3Aug9-Aug9", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover page", "role": "http://www.naturalhealthtrendscorp.com/role/CoverPage", "shortName": "Cover page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "nhtc20190813_8k.htm", "contextRef": "D2019Q3Aug9-Aug9", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.naturalhealthtrendscorp.com/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 17 0000912061-19-000065-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000912061-19-000065-xbrl.zip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end